Empowering Communities: ViiV Healthcare Awards $33 Million in Grants to Advance HIV Response in the U.S.
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced more than $33 million in U.S. community grants awarded in 2026. These investments support 230 community-based organizations in 110 cities across 36 states and territories, inclu…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.